RUNX2 and WWOX genes as molecular biomarkers and candidates for targeted therapy in Egyptian patients with primary conventional osteosarcoma
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Bahnassy, Abeer A.
Rafalla, Awad Abdel Moniem A.
Zekri, Abdel-rahman N.
Yousif, Hend F.
Younis, Layla Kamal
Funding for this research was provided by:
National Cancer Institute, Cairo University (11235-16)